跳转至内容
Merck
CN

G4401

鸟苷 5′-二磷酸-β- L -岩藻糖 钠盐

≥85%, powder

别名:

6-脱氧-β- L -半乳吡喃糖基鸟苷 5′-二磷酸, GDP-Fuc, GDP-海藻糖

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C16H23N5Na2O15P2
化学文摘社编号:
15839-70-0
分子量:
633.31
UNSPSC Code:
12352204
PubChem Substance ID:
24895171
NACRES:
NA.32
MDL number:
MFCD00058553

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

鸟苷 5′-二磷酸-β- L -岩藻糖 钠盐, ≥85%

SMILES string

CC1OC(OP(O)(=O)OP(O)(=O)OCC2OC(C(O)C2O)n3cnc4C(=O)N=C(N)Nc34)C(O)C(O)C1O

InChI

1S/C16H25N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,7-11,14-15,22-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)

InChI key

LQEBEXMHBLQMDB-UHFFFAOYSA-N

assay

≥85%

form

powder

solubility

water: 50 mg/mL, clear, colorless to faintly yellow

storage temp.

−20°C

Quality Level

100

正在寻找类似产品? 访问 产品对比指南

Application

鸟苷5′-二磷酸-β-L-岩藻糖钠盐可用作岩藻糖基转移酶VII(FTVII)反应缓冲液组分，用于鼠脂肪组织来源间充质干细胞(AMSC)的胞外岩藻糖基化。它已用于微生物凝集试验和凝集抑制试验。
鸟苷5′-二磷酸-β-L-岩藻糖钠盐已用于微生物凝集试验和凝集抑制试验。

General description

岩藻糖基转移酶底物
鸟苷5′-二磷酸-β-L-岩藻糖（GDP-岩藻糖）是存在于细菌和人类中的一种核苷酸糖，也是岩藻糖基转移酶的底物。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

涉药品监管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000520830
0000520829
0000520830
0000520829
0000447669

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Qiang Yang et al.
The Journal of biological chemistry, 292(36), 14796-14803 (2017-07-22)
The mammalian α1,6-fucosyltransferase (FUT8) catalyzes the core fucosylation of
Stephen T B Lau et al.
Journal of the American Chemical Society, 130(51), 17593-17602 (2008-12-05)
L-fucose, 6-deoxy-L-galactose, is a key component of many important glycoconjugates including the blood group antigens and the Lewis(X) ligands. The biosynthesis of GDP-L-fucose begins with the action of a dehydratase that converts GDP-D-mannose into GDP-4-keto-6-deoxy-mannose. The enzyme GDP-fucose synthase, GFS
Qiong Wang et al.
Biotechnology and bioengineering, 115(6), 1378-1393 (2018-02-20)
As a key parameter impacting functional and structural heterogeneity, protein glycosylation is a critical quality attribute for antibody biotherapeutic manufacturing. The glycan patterns on recombinant antibodies, particularly on the conserved fragment crystallizable (Fc) region, can have significant effects on an
David García-Bernal et al.
Frontiers in cell and developmental biology, 8, 584074-584074 (2020-12-17)
Mesenchymal stromal cells (MSCs) constitute the cell type more frequently used in many regenerative medicine approaches due to their exclusive immunomodulatory properties, and they have been reported to mediate profound immunomodulatory effects in vivo. Nevertheless, MSCs do not express essential
Daniel C Turnock et al.
The Journal of biological chemistry, 282(39), 28853-28863 (2007-07-21)
The protozoan parasite Trypanosoma brucei causes human African sleeping sickness in sub-Saharan Africa. The parasite makes several essential glycoproteins, which has led to the investigation of the sugar nucleotides and glycosyltransferases required to synthesize these structures. Fucose is a common
查看所有相关文献

商品

Glycosyltransferases

Enzymatic glycosyltransferase specificity challenges the one enzyme-one linkage concept.

Glycosyltransferases: Tools for Synthesis and Modification of Glycans

Explore tools for glycosyltransferase synthesis and modification of glycans, such as glycosyltransferases and nucleotide sugar donors.

Analysis: Activated Nucleotide Sugars by LC-MS/MS

LC-MS/MS method quantifies similar polar nucleotide activated sugars using Supel™ Carbon LC column for simultaneous analysis.

相关内容

Glycobiology Brochure

Glycobiology and Glycoproteomics Brochure

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持